Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity
ROP Imaging
1 other identifier
observational
90
1 country
1
Brief Summary
The goal of this proposal is to develop novel HH-SECTR technology for visualizing and quantifying diagnostic disease features in prematurely born infant retinopathy of prematurity (ROP) patients that lead to more informed clinical decision making. Providing depth-resolved vascular information has not been adequately investigated for its diagnostic potential. Furthermore, we seek to identify disease features not currently accessible by standard examination methods to better inform clinical decisions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2025
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2024
CompletedFirst Posted
Study publicly available on registry
September 25, 2024
CompletedStudy Start
First participant enrolled
February 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2030
May 15, 2025
May 1, 2025
4 years
September 21, 2024
May 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retinal imaging in pediatric ROP patients
Real-time noninvasive optical imaging of the retina will be performed out to the ora serrata and ROP diagnostic markers will be evaluated in post-processing and compared against clinical examination
Weekly imaging until 45 weeks, cessation of ROP screening, or first therapeutic intervention, whichever comes first
Eligibility Criteria
Preterm male and female infants born at 24-34 weeks gestational age and weighing \<1500g at birth.
You may qualify if:
- Preterm male and female infants born at 24-34 weeks gestational age and weighing \<1500g at birth
You may not qualify if:
- Infants surgically treated for ROP
- Infants with significant health concern that would preclude noninvasive retinal imaging as noted by the primary inpatient team
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 21, 2024
First Posted
September 25, 2024
Study Start
February 1, 2025
Primary Completion (Estimated)
February 1, 2029
Study Completion (Estimated)
February 1, 2030
Last Updated
May 15, 2025
Record last verified: 2025-05